INVO Fertility, Inc. - Common Stock (IVF)

CUSIP: 44984F807

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
6,035,686
Total 13F shares
261,578
Share change
+261,578
Total reported value
$196,865
Price per share
$0.77
Number of holders
8
Value change
+$196,865
Number of buys
8

Quarterly Holders Quick Answers

What is CUSIP 44984F807?
CUSIP 44984F807 identifies IVF - INVO Fertility, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IVF - INVO Fertility, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AWM Investment Company, Inc.
3/4/5
10%+ Owner
class O/S missing
1,159,075
$1,101,121 01 Oct 2021
ARMISTICE CAPITAL, LLC
13D/G
10%
602,965
$850,181 $0 31 Dec 2025
Greenblock Capital, LLC
13D/G
10%
617,954
$506,722 $0 25 Jun 2025
Five Narrow Lane LP
13D/G
10%
708,074
$233,664 $0 14 Jan 2025
DRW Securities, LLC
13F
Company
2.8%
174,520
$132,617 30 Sep 2025
13F
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
5%
34,981
$56,319 $0 31 Mar 2025
CITADEL ADVISORS LLC
13F
Company
1.1%
66,849
$50,799 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.67%
41,280
$31,369 30 Sep 2025
13F
Jeffrey Segal
3/4/5
Director
class O/S missing
28,220
$26,809 01 Jun 2022
Virtu Financial LLC
13F
Company
0.26%
16,100
$12,000 30 Sep 2025
13F
MONEY CONCEPTS CAPITAL CORP
13F
Company
0.25%
15,558
$11,823 30 Sep 2025
13F
Matthew K. Szot
3/4/5
Director
class O/S missing
5,646
$3,037 -$6 03 Dec 2025
Tower Research Capital LLC (TRC)
13F
Company
0.04%
2,405
$1,828 30 Sep 2025
13F
SBI Securities Co., Ltd.
13F
Company
0.03%
1,853
$1,408 30 Sep 2025
13F
Steve Shum
3/4/5
Chief Executive Officer, Director
mixed-class rows
43,125
mixed-class rows
$552 26 Aug 2025
Andrea Goren
3/4/5
Chief Financial Officer
mixed-class rows
50,621
mixed-class rows
$173 26 Aug 2025
OSAIC HOLDINGS, INC.
13F
Company
mixed-class rows
54
mixed-class rows
$47 30 Sep 2025
13F
Trent D. Davis
3/4/5
Director
mixed-class rows
45,208
mixed-class rows
$40 26 Aug 2025
Barbara Ryan
3/4/5
Director
mixed-class rows
45,203
mixed-class rows
$37 26 Aug 2025
Rebecca Messina
3/4/5
Director
mixed-class rows
45,176
mixed-class rows
$27 26 Aug 2025
BANK OF AMERICA CORP /DE/
13F
Company
0%
7
$5 30 Sep 2025
13F
HUNTINGTON NATIONAL BANK
13F
Company
0%
1
$1 30 Sep 2025
13F
Westfuller Advisors, LLC
13F
Company
0%
1
$1 30 Sep 2025
13F
Michael Jos. Campbell
3/4/5
Chief Operating Officer, Director
class O/S missing
83,000
18 May 2023
Terah Renee Krigsvold
3/4/5
Chief Financial Officer
0%
1
30 Dec 2025

Institutional Holders of INVO Fertility, Inc. - Common Stock (IVF) as of Q4 2025

As of 31 Dec 2025, INVO Fertility, Inc. - Common Stock (IVF) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 261,578 shares. The largest 8 holders included ARMISTICE CAPITAL, LLC, ADAR1 Capital Management, LLC, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), SBI Securities Co., Ltd., BANK OF AMERICA CORP /DE/, DANSKE BANK A/S, and CITIGROUP INC. This page lists 8 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q4 2025 Across Filers

Q4 2025 holders
8
Q4 2025 holders
8
Holder diff
0
Investor Q4 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q4 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .